The University of Queensland announced that following consultation with the Australian Government, CSL will not progress the UQ-CSL v451 COVID-19 vaccine candidate to Phase 2/3 clinical trials.
Read More
![](https://covid19.healthcare.pro/wp-content/uploads/2020/12/cancelled-5250908.png)
The University of Queensland announced that following consultation with the Australian Government, CSL will not progress the UQ-CSL v451 COVID-19 vaccine candidate to Phase 2/3 clinical trials.
Read More